Cost-utility analysis of the use of a wearable cardioverter defibrillator (LifeVest®) versus standard of care in the prevention of sudden cardiac death in patients after myocardial infarction.
Mitkowski P, Sterliński M, Czech M, Przybylski A, Wranicz JK, Kempa M, Kaźmierczak J, Michalak M, Ptaszyński P, Sokal A, Gierlotka M, Gil RJ, Farkowski MM, Kowalski O, Pawlak A, Szumowski Ł, Tajstra M, Witkowski A, Wojtaszczyk A, Ząbek A, Dobrowolska I, Młyńczak K, Niewada M, Golicki D.
Mitkowski P, et al. Among authors: ptaszynski p.
Kardiol Pol. 2025;83(11):1286-1295. doi: 10.33963/v.phj.108491. Epub 2025 Sep 16.
Kardiol Pol. 2025.
PMID: 40956230
Free article.